| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients
|
Hwang, Hye Won
|
|
2018
|
173 |
2 |
p. 255-266
|
article
|
| 2 |
A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer
|
Blanco, Carlos
|
|
2018
|
173 |
2 |
p. 353-364
|
article
|
| 3 |
Better pathological tumor characteristics might occur in recurrent metastatic breast cancer patients after 10-year metastatic free interval
|
Altundag, Kadri
|
|
2018
|
173 |
2 |
p. 483
|
article
|
| 4 |
Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy
|
van den Berg, Maaike M. G. A.
|
|
2018
|
173 |
2 |
p. 475-481
|
article
|
| 5 |
Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database
|
Mazor, Anna M.
|
|
2018
|
173 |
2 |
p. 301-311
|
article
|
| 6 |
Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis
|
Wang, Jiayu
|
|
2018
|
173 |
2 |
p. 487
|
article
|
| 7 |
Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score
|
Jerevall, Piiha-Lotta
|
|
2018
|
173 |
2 |
p. 375-383
|
article
|
| 8 |
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis
|
Fasching, Peter A.
|
|
2018
|
173 |
2 |
p. 319-328
|
article
|
| 9 |
Extranodular extension in sentinel lymph node-positive breast cancer might predict further initiation of completion axillary lymph node dissection
|
Altundag, Kadri
|
|
2018
|
173 |
2 |
p. 485
|
article
|
| 10 |
High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study
|
Nilsson, Martin P.
|
|
2018
|
173 |
2 |
p. 313-318
|
article
|
| 11 |
Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy
|
Guestini, Fouzia
|
|
2018
|
173 |
2 |
p. 275-288
|
article
|
| 12 |
Improving the competency of medical students in clinical breast examination through a standardized simulation and multimedia-based curriculum
|
Angarita, Fernando A.
|
|
2018
|
173 |
2 |
p. 439-445
|
article
|
| 13 |
Machine learning for diagnostic ultrasound of triple-negative breast cancer
|
Wu, Tong
|
|
2018
|
173 |
2 |
p. 365-373
|
article
|
| 14 |
Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial
|
Li, Jian-wei
|
|
2018
|
173 |
2 |
p. 407-415
|
article
|
| 15 |
Mucin 2 (MUC2) modulates the aggressiveness of breast cancer
|
Astashchanka, Anna
|
|
2018
|
173 |
2 |
p. 289-299
|
article
|
| 16 |
Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set
|
Cain, Elizabeth Hope
|
|
2018
|
173 |
2 |
p. 455-463
|
article
|
| 17 |
One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis
|
Inno, Alessandro
|
|
2018
|
173 |
2 |
p. 247-254
|
article
|
| 18 |
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens
|
Cabel, Luc
|
|
2018
|
173 |
2 |
p. 397-406
|
article
|
| 19 |
Predictors of time to death after distant recurrence in breast cancer patients
|
Sopik, Victoria
|
|
2018
|
173 |
2 |
p. 465-474
|
article
|
| 20 |
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea
|
Ryu, Jai Min
|
|
2018
|
173 |
2 |
p. 385-395
|
article
|
| 21 |
Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis
|
He, Xuexin
|
|
2018
|
173 |
2 |
p. 329-341
|
article
|
| 22 |
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study
|
Classe, Jean-Marc
|
|
2018
|
173 |
2 |
p. 343-352
|
article
|
| 23 |
Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis
|
Jonczyk, Michael M.
|
|
2018
|
173 |
2 |
p. 267-274
|
article
|
| 24 |
The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations
|
Panattoni, Laura
|
|
2018
|
173 |
2 |
p. 417-427
|
article
|
| 25 |
The influence of reconstruction choice and inclusion of radiation therapy on functional shoulder biomechanics in women undergoing mastectomy for breast cancer
|
Leonardis, Joshua M.
|
|
2018
|
173 |
2 |
p. 447-453
|
article
|
| 26 |
Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
|
Hennigs, André
|
|
2018
|
173 |
2 |
p. 429-438
|
article
|
Journal description